scispace - formally typeset
P

Peter W. Lewis

Researcher at University of Wisconsin-Madison

Publications -  54
Citations -  8010

Peter W. Lewis is an academic researcher from University of Wisconsin-Madison. The author has contributed to research in topics: Histone H3 & Histone. The author has an hindex of 30, co-authored 49 publications receiving 6652 citations. Previous affiliations of Peter W. Lewis include Rockefeller University & University of Southern California.

Papers
More filters
Journal ArticleDOI

Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma

TL;DR: It is proposed that K-to-M substitutions may represent a mechanism to alter epigenetic states in a variety of pathologies and be sufficient to cause specific reduction in methylation through inhibition of SET-domain enzymes.
Journal ArticleDOI

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres

TL;DR: It is found that the ATRX–Daxx complex is bound to telomeric chromatin, and that both components of this complex are required for H3.3 deposition at telomeres in murine embryonic stem cells (ESCs).
Journal ArticleDOI

Isolation of the Cdc45/Mcm2–7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase

TL;DR: RNA interference knock-down experiments targeting the GINS and Cdc45 components establish that the proteins are required for the S phase transition in Drosophila cells, and suggest that this complex forms the core helicase machinery for eukaryotic DNA replication.
Journal ArticleDOI

Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

TL;DR: This work integrated whole-genome sequencing with methylation, expression and copy number profiling, discovering that DIPGs comprise three molecularly distinct subgroups (H3-K27M, silent and MYCN) and uncovering a new recurrent activating mutation affecting the activin receptor gene ACVR1 in 20% of DIPG.